Detalles de la búsqueda
1.
Cancer germline antigens and tumor-agnostic CD8+ T cell evasion.
Trends Immunol;
43(5): 391-403, 2022 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35414484
2.
Detection of Low-Frequency Epitope-Specific T Cells in Blood of Healthy Individuals according to an Optimized In Vitro Amplification System.
J Immunol;
209(11): 2239-2247, 2022 12 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36426971
3.
A blood-based immune marker for resistance to pembrolizumab in patients with metastatic urothelial cancer.
Cancer Immunol Immunother;
72(3): 759-767, 2023 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-35976415
4.
HYpofractionated, dose-redistributed RAdiotherapy with protons and photons to combat radiation-induced immunosuppression in head and neck squamous cell carcinoma: study protocol of the phase I HYDRA trial.
BMC Cancer;
23(1): 541, 2023 Jun 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-37312053
5.
Triple-Negative Breast Cancer and Predictive Markers of Response to Neoadjuvant Chemotherapy: A Systematic Review.
Int J Mol Sci;
24(3)2023 Feb 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36769287
6.
Curdlan, zymosan and a yeast-derived ß-glucan reshape tumor-associated macrophages into producers of inflammatory chemo-attractants.
Cancer Immunol Immunother;
70(2): 547-561, 2021 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-32860527
7.
Adoptive T Cell Therapy: New Avenues Leading to Safe Targets and Powerful Allies.
Trends Immunol;
39(11): 921-936, 2018 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-30309702
8.
TCR-engineered T cells to treat tumors: Seeing but not touching?
Semin Immunol;
28(1): 10-21, 2016 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-26997556
9.
Lack of B and T cell reactivity towards IDH1R132H in blood and tumor tissue from LGG patients.
J Neurooncol;
144(1): 79-87, 2019 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-31240524
10.
Tumor heterogeneity, aggressiveness, and immune cell composition in a novel syngeneic PSA-targeted Pten knockout mouse prostate cancer (MuCaP) model.
Prostate;
78(13): 1013-1023, 2018 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-30133757
11.
Association between single-nucleotide polymorphisms and adverse events in nivolumab-treated non-small cell lung cancer patients.
Br J Cancer;
118(10): 1296-1301, 2018 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-29695768
12.
Tumor-infiltrating lymphocytes and ductal carcinoma in situ of the breast: friends or foes?
Mod Pathol;
31(7): 1012-1025, 2018 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-29463884
13.
CD4+ T-cell alloreactivity toward mismatched HLA class II alleles early after double umbilical cord blood transplantation.
Blood;
128(17): 2165-2174, 2016 10 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-27531680
14.
T lymphocytes facilitate brain metastasis of breast cancer by inducing Guanylate-Binding Protein 1 expression.
Acta Neuropathol;
135(4): 581-599, 2018 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-29350274
15.
MAGE-C2-Specific TCRs Combined with Epigenetic Drug-Enhanced Antigenicity Yield Robust and Tumor-Selective T Cell Responses.
J Immunol;
197(6): 2541-52, 2016 09 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-27489285
16.
IL-4 Downregulates IL-1ß and IL-6 and Induces GATA3 in Psoriatic Epidermal Cells: Route of Action of a Th2 Cytokine.
J Immunol;
195(4): 1744-52, 2015 Aug 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-26170379
17.
Plasma IFN-γ and IL-6 levels correlate with peripheral T-cell numbers but not toxicity in RCC patients treated with CAR T-cells.
Clin Immunol;
169: 107-113, 2016 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-27377533
18.
Treatment of metastatic renal cell carcinoma (mRCC) with CAIX CAR-engineered T-cells-a completed study overview.
Biochem Soc Trans;
44(3): 951-9, 2016 Jun 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-27284065
19.
TCRs genetically linked to CD28 and CD3ε do not mispair with endogenous TCR chains and mediate enhanced T cell persistence and anti-melanoma activity.
J Immunol;
193(10): 5315-26, 2014 Nov 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-25320284
20.
Recurrence of melanoma following T cell treatment: continued antigen expression in a tumor that evades T cell recruitment.
Mol Ther;
23(2): 396-406, 2015 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-25363716